Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients.

Finally, those patients who were treated with axi-cel required more platelet units than those who used tisa-cel, although the difference did not reach statistical significance ( Figure 7 A).

also in 111,027 other papers